title: Intensive care for children after orthotopic liver transplantation.
abstract: We report our experience in the management of children after orthotopic liver transplantation (OLT). From 03/84 to 04/87 50 patients (pts) were transplanted. Mean age was 4 3/12 years (8/12 to 13 2/12) and mean body weight 14.7 kg (5.8 to 40). Hospital mortality was 14%. Problems related to the surgery included: Abdominal complications: bleeding (8 pts), infection (18 pts), ascites and fistula (1 pt), need for secondary abdominal surgery (10 patients). Respiratory problems: lobar atelectasis (11 pts), right diaphragmatic paralysis (2 pts) and right pleural effusion (11 pts). Problems related to immunosuppression included: Bacterial infection (29 pts) fungal infection (5 pts), one patient died of disseminated cytomegalovirus infection. Side effect of cyclosporin A (CsA) were systemic blood hypertension (S.B.H.) (47 pts), sinusal bradycardia (37 pts), associated to SBH (24 pts), hypertensive encephalopathy (2 pts). Generalized seizures (2 pts in the absence of SBH). Renal side effects of CsA were hypercreatininemia, decreased sodium bicarbonate and hyperkaliemia. The nephrotoxicity of CsA was favoured by the use of other nephrotoxic drugs such as aminoglycosides, amphotericin B. Edematous pancreatitis was observed in 3 patients and related to the use of large doses of steroids. Problems related to the functioning of the graft included: Primary non-function of the graft (4 pts), hepatic artery thrombosis (8 pts) and severe acute rejection unresponsive to therapy (1 pt); these situations needed to be recognised early in order to organize a second OLT. Other causes of hepatic dysfunction were: portal vein thrombosis (1 pt), biliary tract obstruction (2 pts), angiocholitis (3 pts), right hepatic lobe necrosis (2 pts). Acute hepatic insufficiency in 7 children.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Intensive Care, University of Louvain, Brussels, Belgium.
authors.forename: D
authors.initials: D
authors.lastname: Moulin
authors.forename: S
authors.initials: S
authors.lastname: Clement de Clety
authors.forename: M
authors.initials: M
authors.lastname: Reynaert
authors.forename: M A
authors.initials: MA
authors.lastname: Carlier
authors.forename: F
authors.initials: F
authors.lastname: Veyckmans
authors.forename: D
authors.initials: D
authors.lastname: Claus
authors.forename: J P
authors.initials: JP
authors.lastname: Buts
authors.forename: B
authors.initials: B
authors.lastname: de Hemptinne
authors.forename: J B
authors.initials: JB
authors.lastname: Otte
mesh_terms: D000293:Adolescent; D001530:Belgium; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D007223:Infant; D015278:Intensive Care Units, Pediatric; D016031:Liver Transplantation; D009102:Multiple Organ Failure / Q000503:physiopathology; D011183:Postoperative Complications / Q000503:physiopathology*
chemical_list: D003524:Cyclosporins